Capricor Therapeutics's total assets for Q2 2024 were $38.28M, a decrease of -22.58% from the previous quarter. CAPR total liabilities were $26.78M for the fiscal quarter, a -13.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.